A number of research firms have changed their ratings and price targets for Amrize (NYSE: AMRZ):
- 9/23/2026 – Amrize had its price target lowered by Deutsche Bank Aktiengesellschaft from $64.00 to $56.00. They now have a “buy” rating on the stock.
- 9/22/2026 – Amrize had its price target lowered by UBS Group AG from $57.00 to $42.00. They now have a “neutral” rating on the stock.
- 9/21/2026 – Amrize had its “outperform” rating reaffirmed by Sanford C. Bernstein. They now have a $60.00 price target on the stock.
- 9/18/2026 – Amrize had its price target lowered by Oppenheimer Holdings, Inc. from $62.00 to $55.00. They now have an “outperform” rating on the stock.
- 9/9/2026 – Amrize had its “equal weight” rating reaffirmed by Wells Fargo & Company. They now have a $44.00 price target on the stock, down from $55.00.
- 9/9/2026 – Amrize was downgraded by Citigroup Inc. from “buy” to “cautious”.
- 9/9/2026 – Amrize was downgraded by Wells Fargo & Company from “overweight” to “equal weight”. They now have a $44.00 price target on the stock, down from $55.00.
- 9/2/2026 – Amrize was given a new $40.00 price target by William Blair.
- 9/2/2026 – Amrize was downgraded by JPMorgan Chase & Co. from “overweight” to “neutral”. They now have a $52.00 price target on the stock, down from $57.00.
- 9/2/2026 – Amrize had its “underperform” rating reaffirmed by Bank of America Corporation. They now have a $40.00 price target on the stock, down from $50.00.
- 8/31/2026 – Amrize was downgraded by Weiss Ratings from “hold (c)” to “hold (c-)”.
- 8/24/2026 – Amrize is now covered by DA Davidson. They set a “neutral” rating and a $50.00 price target on the stock.
- 8/24/2026 – Amrize was upgraded by DA Davidson to “hold”.
- 8/19/2026 – Amrize was downgraded by Zacks Research from “hold” to “strong sell”.
- 8/13/2026 – Amrize was upgraded by Weiss Ratings from “sell (d+)” to “hold (c)”.
- 8/12/2026 – Amrize had its price target lowered by Stephens from $65.00 to $54.00. They now have an “overweight” rating on the stock.
- 8/11/2026 – Amrize had its price target lowered by Citigroup Inc. from $66.00 to $58.00. They now have a “buy” rating on the stock.
- 8/10/2026 – Amrize was downgraded by Royal Bank Of Canada from “sector perform” to “underperform”. They now have a $48.00 price target on the stock, down from $60.00.
- 7/31/2026 – Amrize was downgraded by Weiss Ratings from “hold (c-)” to “sell (d+)”.
Amrize Dividend Announcement
The business also recently announced a dividend, which was paid on Wednesday, August 26th. Stockholders of record on Tuesday, August 18th were given a dividend of $0.11 per share. The ex-dividend date of this dividend was Tuesday, August 18th. Amrize’s dividend payout ratio is currently 20.28%.
Insider Activity at Amrize
In other news, insider Stephen S. Clark bought 5,260 shares of the firm’s stock in a transaction that occurred on Tuesday, August 11th. The shares were acquired at an average price of $47.31 per share, with a total value of $248,850.60. Following the acquisition, the insider owned 10,637 shares of the company’s stock, valued at approximately $503,236.47. The trade was a 97.82% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Baris Oran acquired 3,000 shares of the stock in a transaction that occurred on Tuesday, August 11th. The stock was acquired at an average price of $47.38 per share, for a total transaction of $142,140.00. Following the transaction, the chief financial officer directly owned 3,000 shares of the company’s stock, valued at $142,140. This represents a ∞ increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders have purchased 48,983 shares of company stock worth $2,158,755 in the last three months. Corporate insiders own 0.54% of the company’s stock.
Amrize is a North American building materials and solutions company formed through the separation of Holcim’s North American business. The company began trading publicly on the New York Stock Exchange in 2025 under the symbol AMRZ.
Amrize supplies essential construction materials, including cement, aggregates, ready-mix concrete and asphalt. It also provides a range of building products and solutions used in residential, commercial and infrastructure construction, including concrete products, roofing systems and other materials designed to support building and construction projects.
The company serves customers across the United States and Canada through a network of production facilities, distribution operations and local businesses.
See Also
- Five stocks we like better than Amrize
- Hims & Hers Slides Nearly 7% as Legal Pressure Adds to Its Growing List of Risks
- Paychex Plunges, Providing the Entry Investors Have Been Waiting For
- The Case for Buying High-Yield General Mills Just Strengthened
- SanDisk’s $1,800 Breakout Turns Memory Hardware Into a Profit Story
Receive News & Ratings for Amrize Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize Ltd and related companies with MarketBeat.com's FREE daily email newsletter.
